Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections

Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections

Abstract Background To quantitatively compare short-term hard exudates (HEs) alteration in patients with diabetic macular edema (DME) after intravitreal triamcinolone, dexamethasone implant or bevacizumab injections. Methods This retrospective study enrolled DME eyes with HEs that underwent a single...

Full description

Bibliographic Details
Main Authors: Yong Un Shin, Eun Hee Hong, Han Woong Lim, Min Ho Kang, Mincheol Seong, Heeyoon Cho
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Ophthalmology
Subjects:
Bevacizumab
Dexamethasone implant
Diabetic macular edema
Hard exudate
Triamcinolone
Online Access:http://link.springer.com/article/10.1186/s12886-017-0578-0

Internet

http://link.springer.com/article/10.1186/s12886-017-0578-0

Similar Items